Aurobindo Pharma Foundation - Due diligence report

A 360° intelligence report on Aurobindo Pharma Foundation: trust score, financial health, credit view, compliance, directors, growth and dis…

2020-07-20 Hyderabad, Telangana Active Unlisted
Share
Connect MCP
AP Aurobindo Pharma Foundation
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Aurobindo Pharma Foundation — 360° Intelligence Report

Generated from MCA filings & public records
87/100
Trust Score
Low Risk

Aurobindo Pharma Foundation is assessed as Low Risk with a Trust Score of 87/100. Aurobindo Pharma Foundation is an active private not for profit company incorporated in 2020, operating in the Veterinary sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 14 Aug 2026 from the latest processed filings. Aurobindo Pharma Foundation snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
87/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
NITYANANDA REDDY KAMBAM 01234567 Director 01/04/2018 6 yrs Approved
SIVAKUMARAN MEENAKSHISUNDERAM 01234567 Director 01/04/2018 6 yrs Approved
SARATH CHANDRA REDDY PENAKA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Aurobindo Pharma Ltd
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Aurobindo Pharma Ltd Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Latest year revenue grew 1.42.
Operating for 6 years.
Active EPFO - real payroll on record.
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence93/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment66/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 7 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2023
Share transfer (FY 2023)
1.00000000 shares to Nityananda Reddy Kambam
20 Jul 2020
Incorporated
Registered with Roc Hyderabad
Director appointed
NITYANANDA REDDY KAMBAM (Director)
Director appointed
SIVAKUMARAN MEENAKSHISUNDERAM (Director)
Director appointed
SARATH CHANDRA REDDY PENAKA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 2 financial year(s).
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Avi Alimchandani Foundation U85200MH2020NPL347969 Mumbai, Maharashtra, India
Amrit Welfare Foundation U85200MP2022NPL060108 Indore, Madhya Pradesh, India
Project Kindness Foundation U85300HR2022NPL108041 Gurugram, Haryana, India
Danin Enterprises Private Limited U51909WB2004PTC127982 Kolkata, West Bengal, India
Chromed Biosciences Private Limited U73200KA2021PTC155218 Tumkur, Karnataka, India
Smt Rupawanti Harishchandra Jain Welfare Foundation U85200MH2022NPL376410 Mumbai, Maharashtra, India
Rsb Foundation U85200PN2019NPL184371 Pune, Maharashtra, India
Crown Veterinary Services Private Limited U85100MH2015PTC267634 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Aurobindo Pharma Foundation before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Aurobindo Pharma Foundation: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Aurobindo Pharma Foundation - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Aurobindo Pharma Foundation pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Aurobindo Pharma Foundation - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Aurobindo Pharma Foundation an active company?

Aurobindo Pharma Foundation has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Aurobindo Pharma Foundation financially healthy?

Aurobindo Pharma Foundation has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Aurobindo Pharma Foundation?

Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Aurobindo Pharma Foundation?

The ultimate holding entity is Aurobindo Pharma Ltd. 3 active director(s) are on record.

Does Aurobindo Pharma Foundation have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Aurobindo Pharma Foundation up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Aurobindo Pharma Foundation?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.